Lexaria Bioscience (LEXX) Capital Expenditures Growth (3y) (2013 - 2026)
Lexaria Bioscience (LEXX) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
- |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
46.88% |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
- |
| 10 |
Lexaria Bioscience |
7.63 Mn |
2.11 Mn |
20,000.00 |
45.51% |
| Date | Value |
|---|
| Feb 28, 2026 |
45.51% |
| Aug 31, 2025 |
-37.00% |
| May 31, 2025 |
-26.00% |
| Nov 30, 2024 |
-16.53% |
| Aug 31, 2022 |
-92.51% |
| May 31, 2022 |
-67.34% |
| Nov 30, 2021 |
-29.87% |
| May 31, 2019 |
758.49% |
| Feb 28, 2019 |
910.61% |
| Nov 30, 2018 |
241.14% |
| Jan 31, 2014 |
-53.07% |
| Oct 31, 2013 |
-54.30% |
